Access cutting-edge sarcoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access sarcoma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sarcoma treatment provided free
The purpose of this study is to find out whether giving the study drug pembrolizumab in combination with the chemotherapy drugs melphalan and dactinomycin, delivered directly to the affected arm or leg using a technique called isolated limb infusion (ILI), is a safe treatment that can delay the time before your disease gets worse (progresses).
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this sarcoma clinical trial in New York, NY
If you're searching for sarcoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.